$BRTX
Market Cap:
$BRTX SEC Filings
| Filing | Filed On |
|---|---|
| THIRD QUARTER RESULTS AND ORS PRESENTATION | 13 Nov 2024 |
| ADDITIONAL PRELIMINARY PHASE 2 DATA AND REVIEW OF THIRD QUARTER CONFERENCE CALL | 07 Nov 2024 |
| RODMAN & RENSHAW AT THE MARKET OFFERING AGREEMENT | 06 Nov 2024 |
| SHAREHOLDER VOTE | 23 Sep 2024 |
| SECOND QUARTER RESULTS | 13 Aug 2024 |
| PRESS RELEASE RE SECOND QUARTER RESULTS AND CONFERENCE CALL | 06 Aug 2024 |
| RE DELISTING | 24 May 2024 |
| RE: RESTATEMENT | 24 May 2024 |
| RE PRESENTATION MATERIALS | 12 Mar 2024 |
| FORM 8-K DATED FEBRUARY 6, 2024 | 08 Feb 2024 |
| RE AUTOLOGOUS STEM CELL THERAPY POSTER | 05 Feb 2024 |
| PRESS RELEASE RE PRELIMINARY PHASE 2 CLINICAL TRIAL | 01 Feb 2024 |
| SHAREHOLDER VOTE | 15 Sep 2023 |
| FORM 8-K DATED JULY 11, 2023 | 13 Jul 2023 |
| 8-K | 14 Apr 2023 |
| RE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM'S CONSENT | 06 Apr 2023 |
| RE REINCORPORATION | 05 Jan 2023 |
| ANNUAL SHAREHOLDER MEETING | 09 Nov 2022 |
| FORM 8-K RE CERTIFICATE OF DESIGNATION SERIES B | 13 Sep 2022 |
| RE CFO | 08 Dec 2021 |
